1681. Integrated TB/HIV Care under Routine Program Condition - Experience from Hawassa, Ethiopia
Session: Poster Abstract Session: HIV: HIV, Tuberculosis, and NTM
Saturday, October 10, 2015
Room: Poster Hall
Posters
  • Kidist Tarekegn, IDSA_poster22.pdf (231.3 kB)
  • Background: Monitoring and evaluation of TB/HIV care is critical to assess service quality and coverage. Since the inception of TB/HIV collaborative activities in 2005 in Southern Ethiopia, there was no comprehensive evaluation of service provision at a program level. This study aims to assess the implementation of integrated TB/HIV activities in health facilities in Hawassa Town  

    Methods: Using cross sectional study design, data extracted by chart review of sampled 284 HIV/AIDS and 238 TB patients from four health facilities in Hawassa Town, Ethiopia in 2012.  Indicator variables were used to measure TB case finding and management practices after transforming into scales (0 or 1) and weighed to reflect the levels of TB/HIV service integration. Experts’ opinion was used to set a cut off level (75%) to weigh each indicator variable to scale of 0 or 1 and categorize the level of integrated care provided by facilities into “adequate” or “inadequate”. Descriptive and analytic statistics were used

    Results: TB case finding and management in HIV/AIDS clinics was adequate. Ninety five percent and 86% of HIV positive patients were screened for TB at baseline and at last clinical visit respectively. Ninety eight percent, 93% and 81% of TB/HIV co-infected patients were given anti-TB treatment, Co-trimoxazole and Antiretroviral Therapy (ART) respectively, but only 11% of HIV positive individuals without active TB were treated with Isoniazid. Being on ART was found to be a strong positive predictor of TB case finding APOR 7.883 (2.998 – 20.731). Significant proportion (94%) of TB patients were tested for HIV and the HIV prevalence was high (17%). However, only 64% and 73% of TB/HIV co infected patients were provided with ART and Co-trimoxazole respectively, and 22% were not enrolled in HIV care.

    Conclusion: There was adequate integrated TB/HIV care in HIV clinics. However, provision of Isoniazid was low, indicating a greater emphasis on TB treatment than prevention. There was high HIV case finding among TB patients with inadequate HIV care to TB/HIV co infected patients. More focus should be given to TB prevention; avail one stop service or improved referral linkages, and wide distribution of HIV/AIDS resources to other HIV entry points such as TB clinics

    Kidist Tarekegn, MD, Hawassa University College of Medicine and Health Science, Hawassa, Ethiopia, Shumet Lonsako, MD, MSc, MPH, Private, Hyattsville, MD and Fisseha Ghidey, MD, MPH, Infectious Diseases, Infectious Diseases Section, MedStar Washington Hospital Center, Washington DC, DC

    Disclosures:

    K. Tarekegn, None

    S. Lonsako, None

    F. Ghidey, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.